Chanita Hughes Halbert1,2, Melanie Jefferson1, Caitlin G Allen3, Oluwole A Babatunde1, Richard Drake2,4, Peggi Angel2,4, Stephen J Savage2,5, Lewis Frey6, Michael Lilly2,7, Ted Obi8, Jihad Obeid6. 1. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC. 2. Hollings Cancer Center, Medical University of South Carolina, Charleston, SC. 3. Department of Behavioral Sciences and Health Education; Rollins School of Public Health, Emory University, Atlanta, GA. 4. Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC. 5. Department of Urology, Medical University of South Carolina, Charleston, SC. 6. Department of Public Health Sciences, Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC. 7. Division of Hematology-Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC. 8. Ichan School of Medicine at Mount Sinai, New York, NY.
Abstract
PURPOSE: The purpose of this study was to examine racial differences in patient portal activation and research participation among patients with prostate cancer. MATERIALS AND METHODS: Participants were African American and White patients with prostate cancer who were treated with radical prostatectomy (n = 218). Patient portal activation was determined using electronic health records, and research participation was measured based on completion of a social determinants survey. RESULTS: Thirty-one percent of patients completed the social determinants survey and enrolled in the study and 66% activated a patient portal. The likelihood of enrolling in the study was reduced with greater levels of social deprivation (odds ratio [OR], 0.70; 95% CI, 0.50 to 0.98; P = .04). Social deprivation also had a signification independent association with patient portal activation along with racial background. African American patients (OR, 0.48; 95% CI, 0.23 to 0.91; P = .02) and those with greater social deprivation (OR, 0.58; 95% CI, 0.42 to 0.82; P = .002) had a lower likelihood of activating a patient portal compared with White patients and those with lower social deprivation. CONCLUSION: Although the majority of patients with prostate cancer activated their patient portal, rates of patient portal activation were lower among African American patients and those who lived in areas with greater social deprivation. Greater efforts are needed to promote patient portal activation among African American patients with prostate cancer and address access to health information technology among those who live in socially disadvantaged geographic areas.
PURPOSE: The purpose of this study was to examine racial differences in patient portal activation and research participation among patients with prostate cancer. MATERIALS AND METHODS: Participants were African American and White patients with prostate cancer who were treated with radical prostatectomy (n = 218). Patient portal activation was determined using electronic health records, and research participation was measured based on completion of a social determinants survey. RESULTS: Thirty-one percent of patients completed the social determinants survey and enrolled in the study and 66% activated a patient portal. The likelihood of enrolling in the study was reduced with greater levels of social deprivation (odds ratio [OR], 0.70; 95% CI, 0.50 to 0.98; P = .04). Social deprivation also had a signification independent association with patient portal activation along with racial background. African American patients (OR, 0.48; 95% CI, 0.23 to 0.91; P = .02) and those with greater social deprivation (OR, 0.58; 95% CI, 0.42 to 0.82; P = .002) had a lower likelihood of activating a patient portal compared with White patients and those with lower social deprivation. CONCLUSION: Although the majority of patients with prostate cancer activated their patient portal, rates of patient portal activation were lower among African American patients and those who lived in areas with greater social deprivation. Greater efforts are needed to promote patient portal activation among African American patients with prostate cancer and address access to health information technology among those who live in socially disadvantaged geographic areas.
Authors: Hilary Daniel; Sue S Bornstein; Gregory C Kane; Jan K Carney; Heather E Gantzer; Tracey L Henry; Joshua D Lenchus; Joseph M Li; Bridget M McCandless; Beth R Nalitt; Lavanya Viswanathan; Caleb J Murphy; Ayeetin M Azah; Lianne Marks Journal: Ann Intern Med Date: 2018-04-17 Impact factor: 25.391
Authors: Nunzia B Giuse; Taneya Y Koonce; Sheila V Kusnoor; Aric A Prather; Laura M Gottlieb; Li-Ching Huang; Sharon E Phillips; Yu Shyr; Nancy E Adler; William W Stead Journal: Am J Prev Med Date: 2016-09-19 Impact factor: 5.043
Authors: Rachel Gold; Arwen Bunce; Stuart Cowburn; Katie Dambrun; Marla Dearing; Mary Middendorf; Ned Mossman; Celine Hollombe; Peter Mahr; Gerardo Melgar; James Davis; Laura Gottlieb; Erika Cottrell Journal: Ann Fam Med Date: 2018-09 Impact factor: 5.166
Authors: Sandra M Gollhofer; Joachim Wiskemann; Martina E Schmidt; Oliver Klassen; Cornelia M Ulrich; Jan Oelmann; Holger Hof; Karin Potthoff; Karen Steindorf Journal: BMC Cancer Date: 2015-03-27 Impact factor: 4.430
Authors: Thomas A Arcury; Sara A Quandt; Joanne C Sandberg; David P Miller; Celine Latulipe; Xiaoyan Leng; Jenifer W Talton; Kathryn P Melius; Alden Smith; Alain G Bertoni Journal: JMIR Med Inform Date: 2017-11-14
Authors: Ronald Dendere; Christine Slade; Andrew Burton-Jones; Clair Sullivan; Andrew Staib; Monika Janda Journal: J Med Internet Res Date: 2019-04-11 Impact factor: 5.428
Authors: Sean A Fletcher; Maya Marchese; Alexander P Cole; Brandon A Mahal; David F Friedlander; Marieke Krimphove; Kerry L Kilbridge; Stuart R Lipsitz; Paul L Nguyen; Toni K Choueiri; Adam S Kibel; Quoc-Dien Trinh Journal: JAMA Netw Open Date: 2020-03-02